leisure time -WSS

leisure time

author：entertainment 2025-09-04 21:58:43 - browse：76299

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： How one patient went off dialysis — and others can too

Wikipedia

hotspot

WSS

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

New rules on organ donation and transplantation 'will bring chaos'

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

WHO recommends dropping component of many flu vaccines

Will.i.am, Britney Spears release new single, 'Mind Your Business'

FDA official pushes for dedicated emerging pathogens team

hotspot

leisure time

focus

Heart attack and stroke risk calculators need revising

Biogen shutters digital health group, ends Apple study, in cost cutting move

Psychedelics group wrestles with new pharma identity

Court strikes down limits on filming of police in Arizona

Medical leaders decry Supreme Court decision on affirmative action

How the Dana

What does generative AI mean for health care? We asked experts

AbbVie dramatically boosts its spending on lobbying

Medicare details structure of new drug price negotiation program

Intercept Pharmaceuticals sells itself for less than $1 billion

knowledge

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Sudafed saga points to U.S. issues with evaluating older drugs

White House launches permanent pandemic office

Biogen shutters digital health group, ends Apple study, in cost cutting move

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

knowledge

Wikipedia

hotspot

hotspot